Abstract
The aggressive characteristic of dural carotid-cavernous fistula (dCCF) is characterized by elevated intraocular pressure or the presentation of leptomeningeal venous drainage. It is necessary to treat an aggressive dCCF to prevent permanent secondary glaucoma and intracerebral sequelae. The endovascular approach is the treatment modality for dramatic improvement after fistula obliteration. Transvenous catheterizations are performed through the inferior petrosal sinus (IPS) and selection of coil packing within each of the venous drainage channel, such as cavernous sinus (CS)-superior orbital vein (SOV) junction, the connection between the CS and the leptomeningeal vein if there is presence of leptomeningeal drainage. An alternative to the CS and SOV approach can be performed using the transfemoral transvenous or percutaneous approach if cannulation of the IPS fails. Coils are mainly used as the embolic material rather than liquid embolic materials to prevent intracerebral complications and cranial nerve dysfunction. The angiographic endpoint of the endovascular procedure is either subtotal or complete occlusion of the fistula. Any small residual non-aggressive angiographic characteristic can be completely obliterated in a future surgery after routine clinical and radiological follow-up. The results are excellent with a low rate of complications. However, dCCF treatment requires experienced operators with a good understanding of the angiographic architecture and the appropriate skills in endovascular techniques.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Dural carotid-cavernous fistula
- Endovascular treatment
- Transvenous catheterization
- Coil embolization
- IPS cannulation
9.1 Introduction
Dural carotid-cavernous fistulas (dCCFs) or indirect carotid-cavernous fistulas are defined as an abnormal connection between the dural branches of either the external or internal carotid artery and the cavernous sinus (CS) [1]. Bilateral dCCFs are not uncommon [2].
A dCCF is the most frequent dural arteriovenous shunt, and the incidence is more common in Asian populations than in Western countries [3]. Although the exact etiology is unknown, dCCFs are considered to be an acquired disease following different triggers such as venous thrombosis, trauma, or infection [4].
Clinical presentations depend on the pattern of venous drainage of the shunts. Most dCCFs have orbital venous congestion symptoms such as chemosis, exophthalmos, bruit, or visual acuity impairment [5,6,7]. However, dCCFs with cortical venous reflux are associated with the potential risk of neurological deficits or even intracranial hemorrhage (Fig. 9.1) [4,5,6,7].
Nevertheless, arteriovenous fistulas or dural arteriovenous shunts in other locations may drain toward the CS and ophthalmic vein (Figs. 9.2 and 9.3) [8]. Furthermore, cerebral venous drainage may convert into the cavernous sinuses as a rerouting pathway in the presence of venous hyperpressure from an intracranial dural venous thrombosis or venous obstruction (Fig. 9.4) [7]. These conditions may have clinical presentations mimicking a dCCF.
The current classifications for dural arteriovenous fistulas are from Borden, Cognard, and the Bicetre group. They are helpful in understanding the morphology and predicting the natural history or prognosis leading to proper options and timing for treatment (Table 9.1) [7, 9, 10]. However, in the case of dCCFs, these existing classifications are not applicable for practical use in planning treatment. They do not incorporate the special characteristics of dCCFs, such as unilateral or bilateral shunt location, ipsilateral, contralateral or bilateral venous drainage, and the relevant antegrade drainage of the inferior petrosal sinus (IPS). Even the modified Cognard classification, which attempted to describe the morphology and characteristics of shunts and venous drainage [11], does not satisfactorily decide on the proper treatment of fistulas.
In our therapeutic strategy, dCCFs are classified into two groups according to presentation and the pattern of venous drainage.
-
1.
The benign group shows antegrade drainage to the IPS or only retrograde drainage into the superior ophthalmic vein (SOV). Clinically the orbital symptoms of congestion are minimal, and intraocular pressure can be controlled medically. In this group, according to the natural history, spontaneous regression can be expected. In particular, if the SOV is not visualized during manual compression, delayed SOV thrombosis can be anticipated. Patients are then advised to perform this maneuver. Usually, invasive treatment is not required (Fig. 9.5) [7].
-
2.
The aggressive group includes dCCFs with the presence of cortical venous reflux, or even dCCFs with SOV drainage only but uncontrolled elevated intraocular pressure. It is necessary to treat aggressive dCCFs to prevent permanent brain damage, intracranial hemorrhage, or secondary glaucoma (Figs. 9.1 and 9.6).
9.2 Cavernous Sinus Anatomy
To facilitate safety and effective treatment of dCCFs, it is essential to understand and recognize the morphology and functional anatomy of those afferent and efferent venous channels around the CS. The CS is a complex venous sinus with different embryological origins of its venous channels. It plays a major role in the contribution to venous drainage from both the cranial and extracranial structures, including the brain, orbit, pituitary gland, adjacent cranial vault, and nasopharynx.
Mitsuhashi et al. demonstrated the concept of CS anatomy in the patterns of longitudinal venous axes and their communication, which are separated into three axes [12].
-
1.
The medial venous axis is a channel medial to the internal carotid artery and is the primary sinus for the chondrocranium and hypophysis that connects with the contralateral side through the anterior and posterior intercavernous sinuses.
-
2.
The lateral venous axis is a venous channel situated lateral to the cranial nerves for venous drainage from the brain via the superficial middle cerebral vein (SMCV). The posterolateral part drains the superior petrosal sinus and also serves as bridging veins from the brainstem.
-
3.
The intermediate venous axis is the remaining venous channel between the internal carotid artery (ICA) and cranial nerves that connects with the SOV and superficial petrosal vein and drains into the pterygoid plexus through emissary veins in the middle cranial fossa.
The medial and lateral venous axes drain posteriorly into the IPS, which also receives venous drainage from the labyrinth, brainstem, and inferior cerebellar surface through bridging veins (Figs. 9.7, 9.8, and 9.9).
According to this concept of cavernous sinus anatomy, if occlusion of the dCCF shunt is incomplete, the residual shunt flow may be redistributed into the cerebral or ocular venous drainage routes leading to focal brain congestion, hemorrhage, or the deterioration of ocular symptoms [13, 14].
9.3 Arterial Supply to a dCCF
A dCCF usually acquires arterial feeders from meningeal arteries of the external carotid artery (ECA) and/or from the ICA around the CS, which can be ipsilateral, contralateral, or bilateral supply to the shunt.
The most consistent meningeal branches of the cavernous ICA are the meningohypophyseal trunk (MHT) and inferolateral trunk (ILT). There are four major pathways of anastomosis between the ICA and ECA: (1) lateral clival branch of the MHT and clival branch of the ascending pharyngeal artery at the foramen lacerum; (2) anterolateral branch of the ILT and artery of the foramen rotundum at the foramen rotundum; (3) posteromedial branch of the ILT and accessory meningeal artery at the foramen ovale; and (4) posterolateral branch of the ILT and middle meningeal artery at the foramen spinosum [4]. These anastomosis groups should always be kept in mind whenever transarterial embolization is desirable (Fig. 9.10).
9.4 Endovascular Treatment of a dCCF
Any dCCF should be considered for endovascular treatment if there is at least one of the following reasons.
-
1.
Cortical venous reflux into the SMCV or posterior fossa despite no clinical symptoms of venous congestion (Figs. 9.6 and 9.9).
-
2.
A benign type with uncontrolled orbital symptom(s) such as severe proptosis, chemosis, and especially increased intraocular pressure (IOP) because it may lead to secondary glaucoma or impaired visual function (Fig. 9.11).
The goal of treatment is to obliterate the affected shunt compartment. If it is not feasible, the alternate goal is to achieve complete occlusion of the outflow of cortical reflux. Once partial closure of a dCCF is obtained, a follow-up angiogram is required to confirm there is no new acquired dangerous venous drainage.
By reason of the existence of anastomosis between the external and internal carotid systems, a transvenous approach to reach the shunt location of a dCCF is safer when the risk-benefit ratio is a concern. Usually, the embolic material using the transvenous route is a detachable coil; however, a combination of liquid embolic materials, such as n-butyl cyanoacrylate (NBCA) or dimethyl sulfoxide (DMSO) based products, can help to enhance the efficacy of the coil mass or eradicate the residual venous space. Although incomplete occlusion may initially occur, delayed thrombosis after complete curing can be expected (Fig. 9.12).
Much more caution is required when using liquid embolic materials, even when injected into the venous channels, because these materials can penetrate into a dangerous anastomosis.
A suggested decision-making algorithm for treatment of a dCCF is illustrated in Fig. 9.13.
9.5 Transvenous Access
Several venous pathways are available to reach the CS. The shortest and easiest route is the IPS because it can be navigated retrogradely via the internal jugular vein (IJV) without difficulty if it presents. The alternative routes include the anterior facial vein and middle temporal vein to gain access via the SOV. However, the superior petrosal sinus can be reached via the sigmoid sinus is some cases.
9.5.1 Inferior Petrosal Sinus Approach
If the IPS can be visualized as a drainage from the shunt, it is the perfect direct pathway to reach the shunt at the CS. Nevertheless, if it is thrombosed, we can perform blind recanalization without much fear on the basis of anatomy of the IPS which is the tract along the osseous structure (Figs. 9.1, 9.6, and 9.9). In our experience, the trans-IPS is the initial attempt to access the shunts with an 80% success rate of treatment.
9.5.1.1 Ipsilateral IPS Approach
Both arterial and venous femoral punctures are prepared. Once the venous guiding catheter (5F is preferable) reaches the jugular bulb, biplane roadmap fluoroscopy is achieved by injection into the arterial catheter to demonstrate the dCCF and IPS. The working projection of the frontal X-ray tube is recommended to move some degree caudally in Water’s view or semi-Water’s view projection. Using a 038 guidewire to select the IPS, the guiding catheter is then moved forward to keep stability at the IPS. A microcatheter can now easily navigate into the CS for selection of the targeted venous channel or shunting site. A test injection via the microcatheter is necessary to confirm the exact venous channel to be embolized (Fig. 9.14). Selection for coil packing at different positions may be needed depending on the morphology and appearance of the venous drainage outlet from the shunts (Fig. 9.15). In general, coil deployment is suggested from the anterior to posterior while carefully preventing inadvertent coil placement or catheter kickback. If one of these events occurs and it is not possible to reselect the SOV or CS, the contralateral IPS or another route of access must be tried.
If the IPS is not demonstrated, blind recanalization of the IPS should be attempted initially using a 038 guidewire to search for the IPS outlet in the antero-medial direction. If successful, a 5F guiding catheter can be advanced forward at least to the IPS-IJV junction. Then a microcatheter can be advanced over a microguidewire using the “drilling” manipulation gently through the thrombus. A test contrast injection should be repeated every time the microcatheter tip changes position. In our experience, this technique has been successfully used in 70% of cases on average in reaching the posterior part of the CS. Once the posterior CS is reached, it is possible to advance the microcatheter into the anterior compartment of the CS and the outlet of the SOV. Initial packing should be started at the SOV-CS junction. Occlusion at the outlet of the SMCV is also necessary in those cases with cortical reflux (Fig. 9.16). However, in some patients with unfavorable anatomy it is impossible to reach the SOV outlet.
9.5.1.2 Contralateral IPS Approach
This approach is usually desired when the dCCF drainage is contralateral or when ipsilateral IPS access has failed. Using a microcatheter over the microguidewire it is essential to pass through the intercavernous sinus under roadmap fluoroscopy. Upon entering the contralateral CS, a test venogram is suggested. If it is similar to the shunt drainage, superselection is then pursued into each targeted venous channel for coil packing in the same manner as mentioned earlier (Fig. 9.17). The obstacle of this technique is non-visualization of the intercavernous sinus on angiogram. If that is the case, another alternative route of access is required.
9.5.1.3 Approach for Bilateral Dural CCFs
The definition of bilateral dCCFs is shunts at the bilateral cavernous sinuses where each side has separate feeding arteries and each has its own venous drainage. The disease is not uncommon. It was reported in 26% of patients with dCCFs in our series [2]. The concept of endovascular treatment is not different from the unilateral shunt. The trans-IPS approach is still the initial choice of access. If the intercavernous sinus is recognized from an angiogram, the success of embolization of bilateral shunts through the single IPS approach can be expected with side-by-side embolization. The dangerous venous outlet should be accomplished first, followed by the symptomatic venous outlet. Then shunt occlusion will be obtained lastly in the sequence. If bilateral IPSs are available, we usually choose to access the contralateral IPS of the more aggressive side. Under roadmap fluoroscopy, a microcatheter is navigated across the intercavernous sinus to select each targeted venous channel for coil packing. It is then withdrawn back into the ipsilateral CS and followed by the same steps of the maneuver. Coil deployment at the intercavernous sinus may not be needed (Figs. 9.18 and 9.19).
9.5.2 Facial Vein Approach
The superior ophthalmic vein communicates with the angular vein via the nasofrontal vein. The angular vein continues as the anterior facial vein (AFV) and then joins the anterior branch of the retromandibular vein to form the common facial vein which empties into the internal jugular vein at about its mid-cervical segment. However, in the case of an undivided retromandibular vein, the AFV drains directly into the IJV (Fig. 9.20).
Retrograde catheterization along the course of the AFV should be tried under roadmap fluoroscopy by catching an image at late venous phase of the shunt drainage. The guiding catheter should be placed in the AFV as far as possible. A microcatheter is then navigated over the microguidewire to access the angular vein, SOV, and CS in that order. Usually, the most difficulty is at the angular vein and SOV junction due to much angulation and tortuosity. Once the CS is reached, coil deployment should be started as close as possible to the shunt location at the CS to CS-SOV junction until complete occlusion of the dCCF is achieved from the test angiogram.
This alternative route is usually applied after failure of IPS recanalization or failure of a forward microcatheter from the posterior CS to the anterior compartment. Either AFV should be demonstrated to be large enough for retrograde catheterization (Fig. 9.21).
9.5.3 Superficial and Middle Temporal Vein Approach
The supraorbital vein connects to the angular vein and communicates to the middle temporal vein (MTV). The MTV joins the superficial temporal vein (STV). At the level of the parotid gland, the STV is joined by the maxillary vein to form the retromandibular vein. The retromandibular vein divides into the anterior and posterior branches. The anterior branch anastomoses with the AFV, and the posterior branch anastomoses with the posterior auricular vein to be the external jugular vein. In some circumstances, the retromandibular vein is undivided and continues as the external jugular vein.
This is another alternative route to access the SOV. An angiogram in delayed venous phase with projection at the neck is the key to understand the venous outlet and plan for retrograde catheterization. The guiding catheter should be placed as far as possible in the MTV to facilitate movement of the microcatheter to reach the CS (Figs. 9.22 and 9.23).
9.5.4 Superior Petrosal Sinus (SPS) Approach
The SPS approach is considered if the IPS fails recanalization and it is not possible to reach the SOV via the AFV or MTV. The SPS originates in the posterior and superior portion of the CS at the petrous apex, and runs posteriorly and laterally in the superior petrosal sulcus and empties into the distal transverse sinus or transverse-sigmoid junction.
In this maneuver, the guiding catheter is placed in the sigmoid sinus. The SPV is then catheterized with a microcatheter over a microguidewire to the CS. Special consideration is needed, particularly at the acute angle between the sigmoid sinus and the small size of the SPV. Injury during catheterization may lead to subarachnoid hemorrhage. Therefore, a soft microwire with gently manipulation is required.
9.5.5 Direct SOV Puncture
This procedure should be the last option whenever the other routes fail to access the SOV. The procedure is performed under general anesthesia in the hybrid operating room (if available) by an experienced surgeon. The incision is performed at the upper lid or sub-eyebrow to mobilize the angular vein. Using blunt dissection, the SOV is located just below the superior orbital rim. Ultrasound may be useful to identify the SOV. Once SOV is exposed, this vessel is then gently held with a suture and cannulated with a 21G needle. A micropuncture wire is then introduced through the needle into the CS under live fluoroscopy. The SOV runs medial to lateral. A small microguidewire and a microcatheter are then carefully navigated into the dilated SOV. The suture material should be stabilized with a plastic tube during the procedure. Once catherization of the CS is achieved, coil embolization is carried out in the same manner of selection through the SOV as in other pathways. However, if a hybrid operating room is not available, the patient should be transferred to the angiosuite after proper fixation of the introducer sheath. After finishing the procedure, the SOV is manually compressed and followed by suturing (Fig. 9.24).
9.5.6 Transarterial Access
Transarterial embolization is preserved only in dCCF when venous access fails (Fig. 9.25). Much attention and awareness of anastomosis with the ICA must be considered (Fig. 9.7). Liquid embolic materials, such as NBCA and ethylene vinyl alcohol (EVOH), are always the embolic agents of choice. To prevent penetration of the embolic material through the anastomosis, consider using balloon protection at the cavernous ICA when injecting EVOH. In any case, in some particular dCCFs which have a single dilated arterial feeder, the transarterial coil embolization technique can be applied with occlusion at the cavernous inlet and distal artery (Fig. 9.26).
9.5.7 Open Surgery
Open surgery exposure for CS occlusion should be considered as the last option only in cases with cortical reflux when all routes of access to reach the CS by catheterization have failed. A pterional craniotomy and intradural approach to the lateral wall of the CS is performed for the purpose of surgically disconnecting the dangerous venous outlet (Fig. 9.27).
9.6 Complications of Endovascular Embolization
Complications need to be considered in endovascular treatment of dCCFs.
-
1.
Cranial nerve palsy: The coil mass in the CS may cause mass effect to cranial nerves III, IV, and VI resulting in ptosis or ophthalmoplegia [15, 16], particularly when combined with liquid embolization. Nevertheless, most of those ocular symptoms from mass effect will recover within 6 months. Conversely, toxicity of DMSO was reported to cause cranial nerve damage with permanent deficit [17]. Thus, selective coil packing only in the affected venous channel is essential to avoid this undesirable consequence.
-
2.
Iatrogenic vascular injury during blind catheterization through the occluded IPS: Hemorrhaging can occur as a subdural hematoma, direct carotid-cavernous fistula, or subarachnoid hemorrhage, or even intraparenchymal hemorrhage depending on the location of vessel injury (Fig. 9.28).
-
3.
Neurological deficit from arterial occlusion: This is the most dangerous sequela from transarterial embolization using liquid embolic materials. They may easily reflux through the anastomosis between the ECA and ICA that may lead to cerebral infarction or permanent cranial nerve palsy [18].
-
4.
Rerouting drainage into the deep venous system of the brainstem or spinal cord veins after incomplete closure of a dCCF: A follow-up angiogram with planning for complete treatment at least within a few months is recommended in patients with residual venous drainage in the aggressive type of dCCF.
9.7 Conclusion
The aggressive type of dCCF requires treatment with the goal of curing or at least obliterating the dangerous venous outlet and/or symptomatic venous outlet. The transvenous approach to access the CS for coil embolization is a more favorable treatment method to achieve this goal with safety and effectiveness. Selective embolization at the affected venous channel of the CS is feasible. The IPS is suggested as the initial route of access, even though it is not visualized. The other alternative pathways include the anterior facial vein and middle temporal vein as routes to access the SOV. If transarterial embolization is desired, a dangerous anastomosis between the ECA and ICA along with the risk of complications should always be kept in mind. Direct puncture of the SOV and surgery is the option in a dCCF when it is not safely accessible by the endovascular approach.
References
Reynolds MR, Lanzino G, Zipfel GJ. Intracranial dural arteriovenous fistulae. Stroke. 2017;48(5):1424–31.
Churojana A, Sakarunchai I, Aurboonyawat T, et al. Efficiency of endovascular therapy for bilateral cavernous sinus dural arteriovenous fistula. World Neurosurg. 2020; https://doi.org/10.1016/j.wneu.2020.10.001.
Cho YD, Rhim JK, Yoo DH, et al. Transvenous microguide wire looping technique for breach of ipsilateral inferior petrosal sinus occlusions en route to cavernous sinus dural arteriovenous fistulas. Interv Neuroradiol. 2016;22:590–5.
Berenstein A, Lasjaunias PL, TerBrugge KG. Surgical neuroangiography, vol. 2. 2nd ed. Heidelberg: Springer; 2004.
Geibprasert S, Krings T, Pereira V, Pongpech S, Piske R, Lasjaunias P. Clinical characteristics of dural arteriovenous shunts in 446 patients of three different ethnicities. Interv Neuroradiol. 2009;15:395–400.
Suh DC, Lee JH, Kim SJ, Chung SJ, Choi CG, Kim HJ, et al. New concept in cavernous sinus dural arteriovenous fistula: correlation with presenting symptom and venous drainage patterns. Stroke. 2005;36:1134–9.
Cognard C, Gobin YP, Pierot L, Bailly AL, Houdart E, Casasco A, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194:671–80.
Kobkitsuksakul C, Jiarakongmun P, Chanthanaphak E, Pongpech S. Noncavernous arteriovenous shunts mimicking carotid cavernous fistulae. Diagn Interv Radiol. 2016;22(6):555–9.
Borden JA, Wu JK, Shucart WA. A proposed classification for spinal and cranial dural arteriovenous fistulous malformations and implications for treatment. J Neurosurg. 1995;82:166–79.
Geibprasert S, Pereira V, Krings T, et al. Dural arteriovenous shunts: a new classification of craniospinal epidural venous anatomical bases and clinical correlations. Stroke. 2008;39:2783–94.
Wenderoth J. Novel approaches to access and treatment of cavernous sinus dural arteriovenous fistula (CS-DAVF): case series and review of the literature. J Neuro Interv Surg. 2017;9:290–6.
Mitsuhashi Y, et al. Dural venous system in the cavernous sinus: a literature review and embryological, functional, and endovascular clinical considerations. Neurol Med Chir (Tokyo). 2016;56:326–39.
Nakagawa I, Wada T, Nakagawa H, Hironaka Y, Kichikawa K, Nakase H. A rare brainstem hemorrhage during transvenous embolization of a cavernous dural arteriovenous fistula. J Clin Neurosci. 2012;19:589–92.
Lee RJ, Chen CF, Hsu SW, Lui CC, Kuo YL. Cerebellar hemorrhage and subsequent venous infarction followed by incomplete transvenous embolization of dural carotid cavernous fistulas: a rare complication: case report. J Neurosurg. 2008;108:1245–8.
Kim DJ, Kim DI, Suh SH, Kim J, Lee SK, Kim EY, Chung TS. Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol. 2006;27:2078–82.
Lee SH, Cho WS, Kang HS, Kim JE, Cho YD, Yoo DH, Han MH. Newly occurring cranial nerve palsy after endovascular treatment of cavernous sinus dural arteriovenous fistulas. J Neurointerv Surg. 2019;11:1168–72.
Lee JM, Whang K, Cho SM, Kim JY, Oh JW, Koo YM, Hu C, Pyen J, Choi JW. Cranial nerve palsy after onyx embolization as a treatment for cerebral vascular malformation. J Cerebrovasc Endovasc Neurosurg. 2017;19:189–95.
Ashour R, Chavali R. Neuromeningeal access for transarterial intravenous carotid-cavernous fistula embolization. Interv Neuroradiol. 2015;21:234–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Churojana, A., Chankaew, E., Sakarunchai, I. (2022). Dural Carotid-Cavernous Fistula Treatment. In: Lv, X. (eds) Intracranial and Spinal Dural Arteriovenous Fistulas. Springer, Singapore. https://doi.org/10.1007/978-981-19-5767-3_9
Download citation
DOI: https://doi.org/10.1007/978-981-19-5767-3_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-5766-6
Online ISBN: 978-981-19-5767-3
eBook Packages: MedicineMedicine (R0)